Rodney W Lappe - Net Worth and Insider Trading

Rodney W Lappe Net Worth

The estimated net worth of Rodney W Lappe is at least $470,905 dollars as of 2024-06-18. Rodney W Lappe is the Director of Design Therapeutics Inc and owns about 133,024 shares of Design Therapeutics Inc (DSGN) stock worth over $470,905. Details can be seen in Rodney W Lappe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rodney W Lappe has not made any transactions after 2023-09-29 and currently still holds the listed stock(s).

Transaction Summary of Rodney W Lappe

To

Rodney W Lappe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rodney W Lappe owns 2 companies in total, including Mirati Therapeutics Inc (MRTX) , and Design Therapeutics Inc (DSGN) .

Click here to see the complete history of Rodney W Lappe’s form 4 insider trades.

Insider Ownership Summary of Rodney W Lappe

Ticker Comapny Transaction Date Type of Owner
MRTX Mirati Therapeutics Inc 2017-01-06 10 percent owner
DSGN Design Therapeutics Inc 2023-09-29 director

Rodney W Lappe Latest Holdings Summary

Rodney W Lappe currently owns a total of 1 stock. Rodney W Lappe owns 133,024 shares of Design Therapeutics Inc (DSGN) as of September 29, 2023, with a value of $470,905.

Latest Holdings of Rodney W Lappe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DSGN Design Therapeutics Inc 2023-09-29 133,024 3.54 470,905

Holding Weightings of Rodney W Lappe


Rodney W Lappe Form 4 Trading Tracker

According to the SEC Form 4 filings, Rodney W Lappe has made a total of 3 transactions in Design Therapeutics Inc (DSGN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Design Therapeutics Inc is the acquisition of 21,000 shares on September 29, 2023, which cost Rodney W Lappe around $49,350.

Insider Trading History of Rodney W Lappe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rodney W Lappe Trading Performance

GuruFocus tracks the stock performance after each of Rodney W Lappe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rodney W Lappe is -11.65%. GuruFocus also compares Rodney W Lappe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rodney W Lappe within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rodney W Lappe's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rodney W Lappe

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.7 LIMIT LIMIT LIMIT LIMIT LIMIT

Rodney W Lappe Ownership Network

Ownership Network List of Rodney W Lappe

No Data

Ownership Network Relation of Rodney W Lappe

Insider Network Chart

Rodney W Lappe Owned Company Details

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Rodney W Lappe is the 10 percent owner of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , EVP & Chief Commercial Officer Benjamin Hickey , and Interim CFO Aaron Ondrey .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

Over the past 18 months, Rodney W Lappe made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 12,716 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,253 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,475,484 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirati Therapeutics Inc Insider Transactions

No Available Data

Rodney W Lappe Mailing Address

Above is the net worth, insider trading, and ownership report for Rodney W Lappe. You might contact Rodney W Lappe via mailing address: C/o Mirati Therapeutics Inc., 4660 La Jolla Village Drive, Suite 500, San Diego Ca 92121.

Discussions on Rodney W Lappe

No discussions yet.